Milestone Pharmaceuticals Inc. (MIST) Operating income 2018–2025
Milestone Pharmaceuticals Inc. (MIST) annual operating income history from SEC filings — each fiscal year as reported.
-$62.1MFY2025 · since FY2018: -$23.8M → -$62.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$62.1M | -47.6% |
| FY2024 | -$42.1M | +31.1% |
| FY2023 | -$61.1M | -2.4% |
| FY2022 | -$59.6M | -38.5% |
| FY2021 | -$43.1M | +15.1% |
| FY2020 | -$50.7M | +12.4% |
| FY2019 | -$57.9M | -143.0% |
| FY2018 | -$23.8M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More MIST financial trends
MIST RevenueMIST Net incomeMIST Net marginMIST Gross profitMIST Gross marginMIST Operating marginMIST Operating cash flowMIST Free cash flowMIST Capital expendituresMIST Return on equityMIST Stock buybacksMIST Dividends paidMIST Total assetsMIST Total liabilitiesMIST Shareholders’ equityMIST overview →